
AFL
USDAFLAC Incorporated Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$108.830
High
$109.030
Low
$106.690
Volume
0.21M
Company Fundamentals
Market Cap
59.6B
Industry
Insurance - Life
Country
United States
Trading Stats
Avg Volume
2.08M
Exchange
NYQ
Currency
USD
52-Week Range
AI Analysis Report
Last updated: Apr 25, 2025AFL: AFLAC Incorporated Common Stock - Analyzing Recent Moves & What Might Come Next
Stock Symbol: AFL Generate Date: 2025-04-25 07:34:21
Let's take a look at what's been going on with AFLAC lately and what the data we have might suggest.
What the News is Saying
The buzz around AFLAC from recent headlines is a bit of a mixed bag, leaning towards analyst opinions and an important upcoming event.
One piece of news touched on the general importance of health checkups, which makes sense for a company like AFLAC that sells supplemental health insurance. While it highlights the need for their products, it's not really specific news about the company's performance right now.
More directly impacting the stock are the analyst ratings. We've seen a few updates:
- Morgan Stanley lowered their price target slightly, moving it from $105 to $100, while keeping their "Equal-Weight" rating.
- On the flip side, UBS raised their target from $109 to $114, sticking with "Neutral."
- Piper Sandler also bumped their target up significantly, from $118 to $124, maintaining their "Overweight" rating.
- JP Morgan nudged their target up a bit too, from $94 to $96, staying "Neutral."
So, analysts seem to have differing views, with some seeing more upside than others, but one firm did lower their outlook.
The really big news is that AFLAC is set to release its first-quarter financial results after the market closes on April 30th. They'll also host a webcast on May 1st. This is a key date because the actual numbers will give investors a much clearer picture of how the company is doing.
Checking the Price Chart
Looking back at the last few months of price data, AFLAC's stock had a pretty good run from late January through March, climbing from around $105 up past $111. But then things got choppy in early April. We saw a pretty sharp dip, with the price briefly falling below $100 around April 7th.
Since that dip, the stock has recovered some ground. It's been trading in the $108 to $109 range over the last few days of the data we have. The last recorded closing price was $109.14. So, it's bounced back from the early April low but is still below its recent highs from late March.
What the AI Thinks
Our AI model has some specific predictions for the very near term. It's forecasting a drop today, predicting the price will be down about 2.49%. For tomorrow, it sees a small bounce back, up around 0.53%. But then, the day after that, it predicts another, larger drop of about 3.12%.
Overall, the AI seems to be calling for some downward pressure on the stock price in the immediate future. The AI prediction score and direction also lean negative. It even points to a potential support level around $98.83, which is close to that low point we saw in early April.
Putting It All Together: Outlook & What to Watch
Based on the news, recent price moves, and the AI's forecast, the picture for AFLAC right now looks a bit uncertain, especially in the very short term.
- Overall Lean: The analyst opinions are split, the price has been volatile recently (a sharp dip followed by a recovery), and the AI is predicting near-term declines. Plus, the big earnings report is just around the corner. All this suggests a "wait and see" approach might be sensible right now. It's hard to make a strong call either way before those earnings numbers come out.
- Potential Levels to Watch:
- Given the AI's prediction of a dip, you might watch to see if the stock approaches that $98.83 level the AI mentioned, or perhaps the recent low around $97.50 from early April. These could act as support if the price falls, but there's no guarantee.
- On the upside, the recent high around $111-$112 could act as resistance. The take-profit level suggested in some data is $110.59, which fits in this area.
- For managing risk if you currently hold the stock, a potential stop-loss level mentioned is $105.25. This is below the current price and recent trading range, suggesting a point where you might reconsider holding if it drops significantly.
The upcoming earnings report on April 30th is the most important thing to watch. That will likely be the next major driver of the stock price. Until then, things could be choppy, especially if the AI's prediction of near-term drops plays out.
A Bit About the Company
Just to remember, AFLAC is primarily in the business of selling supplemental health and life insurance. This means things like cancer, disability, and accident policies. They operate in both the U.S. and Japan. Their business performance is tied to factors like employment levels (people buying insurance through work) and healthcare trends. The news about people putting off checkups, while not directly about AFLAC, does highlight the health landscape they operate in.
Important Note: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are unpredictable, and prices can go down as well as up. You should always do your own thorough research or consult with a qualified financial advisor before making any investment decisions.
Related News
9 in 10 Americans have put off health checkups and screenings that could help save their lives
April is National Cancer Prevention and Early Detection Month, a time to emphasize the importance of preventive health care and the value of early...
Morgan Stanley Maintains Equal-Weight on Aflac, Lowers Price Target to $100
Morgan Stanley analyst Nigel Dally maintains Aflac with a Equal-Weight and lowers the price target from $105 to $100.
Aflac Incorporated to Release First Quarter Results and CFO Video Update on April 30, 2025 and Host Webcast on May 1, 2025
Aflac Incorporated (NYSE: AFL) announced today that it will release first quarter 2025 financial results after the market closes on April 30, 2025....
UBS Maintains Neutral on Aflac, Raises Price Target to $114
UBS analyst Brian Meredith maintains Aflac with a Neutral and raises the price target from $109 to $114.
Piper Sandler Maintains Overweight on Aflac, Raises Price Target to $124
Piper Sandler analyst John Barnidge maintains Aflac with a Overweight and raises the price target from $118 to $124.
JP Morgan Maintains Neutral on Aflac, Raises Price Target to $96
JP Morgan analyst Jimmy Bhullar maintains Aflac with a Neutral and raises the price target from $94 to $96.
AI PredictionBeta
AI Recommendation
Updated at: Apr 27, 2025, 10:01 PM
65.0% Confidence
Risk & Trading
Entry Point
$107.51
Take Profit
$110.08
Stop Loss
$104.64
Key Factors
Related Stocks

MTB
M&T Bank

WEL
Integrated Wellness Acquisition Corp Ordinary Shares

VLRS
Controladora Vuela Compania de Aviacion S.A.B. de C.V. American Depositary Shares each representing ten (10) Ordinary Participation Certificates

IBM
IBM

ALL
Allstate
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.